HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beta-cell function and metabolic control in insulin treated diabetics.

Abstract
In a random one day study beta-cell function was evaluated in 210 insulin treated diabetics by the serum C-peptide concentration 6 min after iv injection of 1 mg of glucagon. Sixty-five patients (31%) had residual beta-cell function. As a group these patients were characterized by having a higher age at onset of diabetes (P less than 0.01), a shorter duration of disease (P less than 0.01) and by receiving a smaller dose of insulin (P less than 0.01). However, their quality of metabolic control did not differ from the patients without beta-cell function. Although the concentrations of post-stimulatory C-peptide correlated inversely with both the 24-hour glycosuria (P less than 0.01) and the fasting blood glucose concentrations (P less than 0.02), only a subgroup with C-peptide concentrations exceeding 0.30 pmol/ml showed a definitely better degree of metabolic control than those without beta-cell function. As this subgroup also received the smallest dose of insulin these observations suggest that maintenance of beta-cell function above this level facilitates good metabolic control. Evidence is presented suggesting that measurements of the 24-hour glycosuria undertaken in a diabetes clinic create a too optimistic impression of the quality of metabolic control during every day life.
AuthorsS Madsbad, P McNair, O K Faber, C Binder, C Christiansen, I Transbøl
JournalActa endocrinologica (Acta Endocrinol (Copenh)) Vol. 93 Issue 2 Pg. 196-200 (Feb 1980) ISSN: 0001-5598 [Print] Denmark
PMID6990673 (Publication Type: Journal Article)
Chemical References
  • Blood Glucose
  • C-Peptide
  • Insulin
Topics
  • Adolescent
  • Adult
  • Aged
  • Blood Glucose (analysis)
  • C-Peptide (blood)
  • Child
  • Diabetes Mellitus (drug therapy, metabolism, physiopathology)
  • Diabetes Mellitus, Type 1 (drug therapy, metabolism, physiopathology)
  • Female
  • Glycosuria
  • Humans
  • Insulin (administration & dosage, therapeutic use)
  • Islets of Langerhans (physiology)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: